Biosimilars: Separating Hype from Reality, Rethinking the Sales Force Business Model in a Dramatically Changing Environment, Deerfield Foundation, From our Foundation Partners, Meet the Associates, IP Corner
Message from Deerfield Managing Partner, James E. Flynn, on COVID-19
During these extraordinary times, we’d like to take a moment to salute the devoted, selfless individuals who are on the frontlines of the COVID-19 pandemic. You are our heroes, and we thank you for your hard work and dedication.
At Deerfield, we remain committed to our Foundation partners, especially those hit hardest by the crisis. We have pledged approximately 10 percent of our Foundation’s annual budget toward emergency funding to organizations in need of urgent resources in order to provide care to their communities.
Importantly, we also want to commend our partners across the healthcare industry who are working tirelessly to care for patients, find a cure or a vaccine, ramp up testing, and accelerate production of essential ventilators, masks and other critical supplies to keep our nation’s healthcare workers safe as they put their own lives on the line.
Our hearts go out to everyone who has been affected by this crisis. The times ahead will be tough, but together, we will get through this and come out stronger than ever.